All In MedTech

Device Trial Radar · NCT03200288

A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis

A Phase 3,Randomized,Double-blind,Placebo-controlled Study to Evaluate the Clinical Performance and Safety of an Intra-articular Solution of High and Low Molecular Weight Hyaluronic Acid (HL-01) in the Treatment of Pain in Symptomatic Knee Osteoarthritis

Last checked: Nov 19, 2026Latest source record: Nov 16, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 692 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

692

Actual

Start

Jun 29, 2017

Primary completion

Jun 27, 2018

Study completion Oct 30, 2018

Sponsor

Lead sponsor
IBSA Institut Biochimique SANot on our public-company list
Sponsor type
Industry
First posted
Jun 27, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to evaluate the Clinical Performance and Safety of a single intra-articular (i.a.) injection of hyaluronic acid product (as HL-01) in the treatment of pain due to osteoarthritis (OA) of the knee.

Conditions

  • Knee Osteoarthritis

Interventions

  • HL-01: high and low molecular weight hyaluronic acidDevice

    2 ml intra-articular single injection

  • PlaceboDevice

    2 ml intra-articular single injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in VAS (Visual Analogue Scale) pain scoreTime frame: Baseline-week 24

Locations

31 sites in 5 countries. Site status is shown where the registry gives one.

  • CHU Centre Ville (Brull) - Bone Metabolism Unit

    Liège, Belgium

  • Rheumazentrum Prof. Dr. med. Gunther Neeck

    Bad Doberan, Germany

  • Klinische Forschung Berlin-Mitte GmbH

    Berlin, Germany

28 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.